跳至主要内容
临床试验/NCT06796283
NCT06796283已完成不适用

Research on AIS Recurrence Risk Prediction Model Using XGBoost Combined With Convolutional Neural Network Algorithm

Second Affiliated Hospital of Nanchang University1 个研究点 分布在 1 个国家目标入组 2,628 人开始时间: 2021年4月26日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,628
试验地点
1
主要终点
Recurrent ischemic stroke,

研究概览

简要总结

The purpose of this observational study is to construct a recurrence risk prediction model for ischemic stroke within 1, 3, 6, and 12 months using XGBoost combined with Convolutional Neural Network (CNN) algorithm.

Method: Follow up was conducted on the study subjects at 1, 3, 6, and 12 months after discharge.

Follow up primary outcome: Whether the study subjects experienced recurrent stroke events.

Secondary outcome: Improved Rinkin score.

Collect information on research subjects:

It includes demographic data, physical examination, medical history, imaging images, medication use, scale scores, CYP2C19 genotype test results, laboratory tests, and other complex multidimensional data.

详细描述

This project conducts a one-year follow-up on the enrolled subjects (patients with ischemic stroke) to observe the recurrence and modified Rankin scores after discharge. Combining complex multidimensional data such as demographic information, physical examination, medical history, imaging images, medication status, NIHSS scale scores, Glasgow Coma Scale scores, CYP2C19 genotype test results, and laboratory examinations of the subjects; Convolutional Neural Networks (CNNs) are used to segment lesions and extract features from the subjects' imaging images; Cox regression models are employed to obtain factors influencing recurrence; a prediction model for the risk of recurrence within 1, 3, 6, and 12 months for ischemic stroke is constructed using the XGBoost algorithm combined with Convolutional Neural Networks. The exploration aims to provide new insights and methods for the prevention and control of major chronic diseases by evaluating the effectiveness of XGBoost in predicting the risk of ischemic stroke recurrence at different times.

  1. Inclusion Criteria:
  • 18-85 years old;
  • Diagnosed with ischemic stroke or transient ischemic attack (diagnosis meets the criteria established by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association in 2014);
  • During the acute phase of onset (2 weeks);
  • Voluntarily participate and sign an informed consent form.
  1. Exclusion criteria:
  • Cancer patients;
  • Cardiogenic infarction, cerebral infarction of other causes, and cerebral infarction of unknown causes;
  • Patients with hemorrhagic stroke, mixed stroke, and tumor stroke;
  • Merge with severe heart, lung, and liver system diseases;
  • Researchers identify patients with poor compliance and inability to complete long-term follow-up;
  • Patients currently participating in any clinical trials related to investigational drugs or medical devices.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 18-85 years
  • Diagnosed with ischemic stroke or transient ischemic attack (diagnosis in accordance with the standards set by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association in 2014)
  • Within the acute phase of the illness (within 2 weeks)
  • Voluntarily participates and signs an informed consent form

排除标准

  • Patients with cancer
  • Patients with cardiogenic infarction, other causes of cerebral infarction, or cryptogenic cerebral infarction
  • Patients with hemorrhagic stroke, mixed stroke, and tumor stroke
  • Patients with severe heart, lung, or liver system diseases
  • Patients judged by the researcher to have poor compliance and unable to complete long-term follow-up
  • Patients currently participating in any clinical trials related to investigational drugs or medical devices

结局指标

主要结局

Recurrent ischemic stroke,

时间窗: April 6th, 2021- March 12th, 2024

Follow up was conducted on the study subjects at 1, 3, 6, and 12 months after discharge, with the main outcome being whether the study subjects experienced stroke recurrence events

次要结局

  • modified Rankin score(April 6th, 2021- March 12th, 2024)

研究者

发起方
Second Affiliated Hospital of Nanchang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验